Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
NATALIZUMAB 300 MG/15ML IV CONC (NDC 64406000801) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 9, 2026 , from http://ppman.hank.ai/transparency/procedure/64406000801/by-state?code_type=NDC
“NATALIZUMAB 300 MG/15ML IV CONC (NDC 64406000801) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/64406000801/by-state?code_type=NDC. Accessed
November 9, 2026 .
“NATALIZUMAB 300 MG/15ML IV CONC (NDC 64406000801) by State,” HANK Price Transparency ,
accessed November 9, 2026 ,
http://ppman.hank.ai/transparency/procedure/64406000801/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
64406000801 — Natalizumab 300 Mg/15ml IV Conc
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$16,649
National median
$10,245 – $19,041
IQR (p25 – p75)
15
hospitals filing
6
states
Walking in without insurance?
Cash / self-pay price
Cash median
$14,087
vs. negotiated
-15.4%
Hospitals reporting
37
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 64406000801 (NDC), with interquartile range
State Median p25 p75
NJ $40,294 $17,806 $73,252
CA $17,929 $12,064 $19,210
AL $16,649 $12,420 $22,476
MI $15,883 $12,809 $18,687
OH $13,037 $4,334 $15,594
NC $25 $24 $34